S H Kelkar reports 14% revenue surge in Q1FY27, EBITDA up 21%
S H Kelkar & Company Limited delivered strong Q1FY27 results with revenue growing 14% to ₹662 crore and EBITDA rising 21% to ₹89 crore. The performance was driven by robust demand in the Fragrance and Flavour segments, particularly in international markets. Despite a rise in net debt to ₹852 crore due to strategic inventory and capex, margins improved to 13.4%. Management remains focused on deleveraging from Q3FY27 and expanding its footprint in Europe and the USA.
*this image is generated using AI for illustrative purposes only.
S H Kelkar & Company Limited reported a robust start to FY27, with consolidated revenue from operations growing 14% year-on-year to ₹662 crore for the quarter ended June 30, 2026. The fragrance and flavour specialist attributed the growth to strong performance in the Fragrance segment, particularly in Europe and select international markets, alongside broad-based growth in the Flavour segment. Consolidated EBITDA rose 21% to ₹89 crore, expanding margins to 13.4% from 12.6% in the corresponding quarter of the previous year, aided by operating leverage on the higher revenue base.
The financial results were reviewed by the Audit Committee and approved by the Board of Directors on July 28, 2026. Deloitte Haskins & Sells LLP, the statutory auditors, issued an unmodified opinion on the unaudited standalone and consolidated financial statements. The disclosure was made on July 29, 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A virtual conference call with investors and analysts was held on the same day to discuss the performance.
Segment Performance and Operational Drivers
Management highlighted that the Flavour segment’s growth was partly influenced by the timing of customer orders, suggesting that the pace should be viewed on an annualized basis rather than extrapolated from a single quarter. Whole-time Director and Group CEO Kedar Vaze noted that while overall revenue met budget expectations, the product mix skewed towards flavours, which outperformed, while the Global Ingredients business saw muted growth due to lower demand in select export markets.
In the Fragrance segment, reported profitability absorbed higher operating expenses linked to investments in R&D capabilities and the global Creative Development Center (CDC) network. These are described as deliberate growth-oriented investments intended to secure larger briefs and build durable positions in European and American markets. Gross margins remained stable year-on-year, supported by a favourable product mix and proactive raw material planning amidst input price volatility.
| Key Financial Metrics | Q1FY27 | Q1FY26 | YoY Change |
|---|---|---|---|
| Revenue from Operations | ₹662 crore | Not Disclosed | +14% |
| Consolidated EBITDA | ₹89 crore | Not Disclosed | +21% |
| EBITDA Margin | 13.4% | 12.6% | +80 bps |
Balance Sheet and Cash Flow Dynamics
Net debt increased by ₹65 crore during the quarter to ₹852 crore as of June 2026. Group Chief Financial Officer Jagdish Agarwal explained this increase as a result of two conscious decisions: strategic inventory buildup to ensure supply security amid geopolitical uncertainties in West Asia, and continued capital deployment towards capacity expansion. The company recognized exceptional income of approximately ₹30 crore towards an insurance claim relating to a past fire incident, with full settlement expected within the current financial year.
Looking ahead, management indicated that net debt is expected to remain broadly at current levels through September before deleveraging begins in earnest from Q3FY27 onwards, with an expectation of reducing debt by approximately ₹25 crore quarter-on-quarter thereafter. Depreciation expenses are projected to rise from the current run rate of ₹35 crore per quarter to ₹38–39 crore per quarter once the Vanvate plant capitalizations are completed.
What the Numbers Show
The improvement in EBITDA margin despite higher R&D spend indicates effective cost management and pricing power, particularly given the geopolitical headwinds affecting raw material costs. The significant rise in net debt is not driven by operational cash flow deficits but by strategic inventory hoarding and capex, signaling management’s confidence in future demand continuity. The divergence between the high-growth Flavour segment and the softer Global Ingredients business highlights a shifting revenue mix, where premiumisation and international expansion in fragrances and flavours are offsetting traditional ingredient supply challenges. With a target long-term ROCE of 20%, the current investment phase in Europe (Germany, UK, USA) is critical; management expects these new centers to reach EBITDA breakeven within three years.
Historical Stock Returns for SH Kelkar & Company
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.67% | -9.33% | +20.95% | -0.04% | -27.78% | +10.43% |
How will the completion of the Vanvate plant capitalizations and the subsequent rise in depreciation expenses impact the company's free cash flow generation in Q3FY27?
What specific strategies is S H Kelkar employing to mitigate the risk of inventory obsolescence given the strategic buildup aimed at countering West Asian geopolitical uncertainties?
Given the muted growth in the Global Ingredients business, what operational changes or market pivots are planned to revitalize this segment in the medium term?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
